SavedAdd your journal

Journals / Turkish Journal of Pediatrics / 2019 / Cilt: 61 - Sayı: 4

Fanconi anemia: a single center experience of a large cohort

Selman KESİCİ
Şule ÜNAL
Barış KUŞKONMAZ
Selin AYTAÇ
Mualla ÇETİN
Fatma GÜMRÜK
Pages
477–488
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Hematopoietic stemcell transplantation was found to have a good impact on survival of patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Fanconi anemia (FA) is an inherited disease, characterized by congenitalmalformations, short stature, progressive bone marrow failure andpredisposition to leukemia and solid tumors.
📊
Key Findings & Data:The aim of this study was toevaluate the clinical and prognostic features of FA patients followed in asingle center.The charts of FA patients were reviewed 35 years retrospectively and a total of175 patients were included in the study in which 51.4% of patients were male.The mean age at diagnosis was 6.3±4.1 years.
💡
Conclusion & Impact:Hematopoietic stemcell transplantation was found to have a good impact on survival of patients.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Fanconi anemia (FA) is an inherited disease, characterized by congenitalmalformations, short stature, progressive bone marrow failure andpredisposition to leukemia and solid tumors. The aim of this study was toevaluate the clinical and prognostic features of FA patients followed in asingle center.The charts of FA patients were reviewed 35 years retrospectively and a total of175 patients were included in the study in which 51.4% of patients were male.The mean age at diagnosis was 6.3±4.1 years. The incidence of microcephalywas 92.6%, skin findings were 88.0%, eye abnormality was 74.3%, thumband radius abnormality was 53.1%, urinary system abnormality was 30.9%,skeletal system abnormality other than thumb and radius was 18.9%, genitalsystem abnormality was 11.4%, cardiovascular system abnormality was11.4%, ear and hearing abnormalities were 9.7% and gastrointestinal systemabnormality was 5.7%. Short stature was present in 75.4% of the patients.Of the 175 patients 167 (95.4%) developed bone marrow failure duringfollow-up and the mean age of bone marrow failure was 7.1 ±3.7 years (1month-old-19.8 years). The first clinical symptom was thrombocytopenia in83.4% of patients. Malignancy developed in a total of 23 (13.1 %) patients(20 leukemia, 3 solid tumors) during follow-up. Of 175 patients, 35 (20%)underwent hematopoietic stem cell transplantation. Fatality rate amongpatients who underwent hematopoietic stem cell transplantation was 31.4%(11/35) and fatality rate among other patients was 63.4% (83/131; p<0.05).Of 94 patients who deceased, death was due to bleeding in 44.7%, infectionin 34%, leukemia progression in 16.0% and graft versus host disease in 5.3%.In terms of the number of patients included, this study is one of the largestcohorts with a remarkable duration of follow-up time. Hematopoietic stemcell transplantation was found to have a good impact on survival of patients.

🔖

Cite This Article

KESİCİ, S., ÜNAL, Ş., KUŞKONMAZ, B., AYTAÇ, S., ÇETİN, M., GÜMRÜK, F. (2019). Fanconi anemia: a single center experience of a large cohort. Turkish Journal of Pediatrics, Cilt: 61 - Sayı: 4, 477–488. https://ajindex.com/articles/411896

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Auerbach AD, Wolman SR. Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature 1976; 261: 494-496
  2. Schroeder TM, Tilgen D, Krüger J, Vogel F. Formal genetics of Fanconi's anemia. Hum Genet 1976; 32: 257-288
  3. Alter BP. Bone marrow failure syndromes. Clin Lab Med 1999; 19: 113-133
  4. Callen E, Casado JA, Tischkowitz MD, et al. A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain. Blood 2005; 105: 1946- 1949
  5. Datta A, Brosh RM Jr. Holding All the cards-how Fanconi anemia proteins deal with replication stress and preserve genomic stability. Genes (Basel) 2019; 10: 170
  6. Alter B. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Look AT, Ginsburg D (eds). Nathan's and Oski's Hematology of Infancy and Childhood (6th ed). WB Saunders: Philadelphia, 2003: 281-365
  7. Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003; 101: 1249-1256
  8. Giampietro PF, Verlander PC, Davis JG, Auerbach AD. Diagnosis of Fanconi anemia in patients without congenital malformations: An International Fanconi Anemia Registry Study. Am J Med Genet 1997; 68: 58-61
  9. Giri N, Batista DL, Alter BP, Stratakis CA. Endocrine abnormalities in patients with Fanconi anemia. J Clin Endocrinol Metab 2007; 92: 2624-2631
  10. Auerbach AD. Diagnosis of Fanconi anemia by diepoxybutane analysis. Curr Protoc Hum Genet 2015; 85: 8.7.1-8.7.17
  11. Francies FZ, Wainwright R, Poole J, et al. Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei. DNA Repair (Amst) 2018; 61: 17-24
  12. Auerbach AD.Diagnosis of fanconi anemia by diepoxybutane analysis. Curr Protoc Hum Genet 2003; 37: 8.7.1-8.7.15
  13. Kuskonmaz B, Unal S, Bayhan T, et al. Successful outcome with fludarabine-based conditioning regimen for hematopoietic stem cell transplantation from related donor in Fanconi anemia: A single center experience from Turkey. Pediatr Blood Cancer 2016; 63: 695-700
  14. Bessler M, Mason PJ, Link DC, Wilson DB. Inherited bone marrow failure syndromes. In: Orkin SH, Nathan DG, Ginsburg D, Look AT, Fisher DE (eds). Nathan's and Oski's Hematology of Infancy and Childhood (7th ed). WB Saunders: Philadelphia, 2009: 307-395
  15. Fiesco-Roa MO, Giri N, McReynolds LJ, Best AF, Alter BP. Genotype-phenotype associations in Fanconi anemia: A literature review. Blood Rev 2019; 37: 100589. 1